Bio-Social Pathways Linking Socioeconomic Adversity to Obesity
将社会经济逆境与肥胖联系起来的生物社会途径
基本信息
- 批准号:10732033
- 负责人:
- 金额:$ 12.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-17 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAfrican AmericanAfrican American populationAtherosclerosis Risk in CommunitiesBiologicalBiological ProcessBiologyBiosocialBody mass indexCardiovascular DiseasesCentral obesityClassificationClinicalCohort StudiesComplexCytosineDNA MethylationDataData AnalysesDisease OutcomeDisparityDyslipidemiasEconomic BurdenEducationEnvironmentEpidemiologyEpigenetic ProcessEthnic OriginEthnic PopulationEtiologyEuropeanEventFunctional disorderFundingGene ExpressionGenesGeneticGenetic VariationGenomicsGrantGuanineHealth Disparities ResearchHeterogeneityHispanicImpairmentIncomeIndividualInflammationInterventionInvestigationJackson Heart StudyJapanese AmericanLatinoLearningLifeLife Cycle StagesLife ExperienceLinkMeasuresMediatingMetabolicMethylationMinorityModelingNational Heart, Lung, and Blood InstituteNative HawaiianObesityObesity EpidemicOccupational StatusOccupationsPathway interactionsPhenotypePopulationPopulation HeterogeneityPrevalencePublic HealthRaceReportingResearchResearch ProposalsRiskRisk FactorsRoleSamplingShapesSiteSkinSocioeconomic StatusSourceSurveysTechniquesTestingTimeTranslatingUnited States National Institutes of HealthWomen&aposs HealthWorkadult obesityblood pressure elevationburden of illnesscardiometabolismcardiovascular disorder riskcohortdisease disparitydisorder riskepigenomicsethnic disparityethnic diversityethnic minorityexperiencehealth disparityimprovedinnovationinorganic phosphatemulti-ethnicnew therapeutic targetnovelnovel markerobesity riskpharmacologicpopulation healthracial disparityracial diversityracial minorityracial populationsexsocialsocial determinantssocioeconomic adversitysocioeconomicsstudy population
项目摘要
PROJECT SUMMARY
Over the past 40 years, the prevalence of obesity has increased markedly in the US—doubling among adults
and disproportionately affecting racial/ethnic minorities. This has increased the clinical, social and economic
burden of cardiovascular disease (CVD) for the public, and especially so for minorities. CVD and its antecedent
risk factors (i.e., obesity, dyslipidemia, inflammation, elevated blood pressure) also display notable disparities
in risk. For example, obesity risk varies by socioeconomic status, SES, i.e. by educational attainment, income,
occupational status; yet, it is unclear exactly how socioeconomic adversity is translated into the biologic
changes that lead to greater disease burden. Epigenetics provides a framework for testing how adverse
environments and life experiences change biologic processes and shape disease risk. Our study will leverage
~9,000 ancestrally diverse individuals four large racially/ethnically diverse NIH-funded cohorts: Atherosclerosis
and Risk in Communities (ARIC), Women’s Health Initiative, Jackson Heart Study, and the Multi-Ethnic Cohort
Study with existing data to test if DNA methylation is a biologic mechanism through which SES leads to obesity
and downstream cardiometabolic dysfunction. Our preliminary analyses in ARIC African Americans identified
differential DNA methylation associated with components of socioeconomic adversity at several obesity-related
genes, lending strong and convincing support for our innovative hypotheses. Herein, we propose a
comprehensive analysis of extant methylation data from five race/ethnic groups using a composite score of
SES as well as multiple obesity measures. Our two specific aims will: 1) identify DNA methylation sites that
mediate the association between socioeconomic adversity and obesity, independent of local genetic variation;
and 2) integrate all available bio-social data to model the pathways between SES, obesity and ultimately CVD
outcomes. Funding from this grant mechanism will allow us to describe extent that DNA methylation sites are
associated with SES and/or obesity, and how these changes (or their interactions with SES) vary across
race/ethnic groups to contribute to CVD disparities. Our study is innovative due to its unprecedented
integration of survey, examination, and DNA methylation-typing on an ancestrally diverse sample. This
project’s anticipated findings will improve both our mechanistic understanding of obesity and CVD, and our
ability to identify potentially-actionable public health or pharmacologic interventions for CVD in diverse
populations.
项目概要
过去 40 年来,美国肥胖患病率显着上升——成年人中肥胖率增加了一倍
这增加了临床、社会和经济方面的影响。
公众的心血管疾病(CVD)负担,尤其是少数群体的心血管疾病(CVD)负担。
危险因素(即肥胖、血脂异常、炎症、血压升高)也表现出显着差异
例如,肥胖风险因社会经济地位、SES(即教育程度、收入)而异。
职业地位;然而,尚不清楚社会经济逆境究竟如何转化为生物地位
导致更大疾病负担的变化提供了一个框架来测试不利程度。
环境和生活经历会改变生物过程并影响疾病风险。
约 9,000 名祖先不同的个体,四个由 NIH 资助的种族/族裔多元化的大型队列: 动脉粥样硬化
和社区风险 (ARIC)、妇女健康倡议、杰克逊心脏研究和多种族队列
利用现有数据进行研究,测试 DNA 甲基化是否是 SES 导致肥胖的生物学机制
我们对 ARIC 非洲裔美国人的初步分析发现。
差异DNA甲基化与一些肥胖相关的社会经济逆境的组成部分相关
基因,为我们的创新假设提供强有力和令人信服的支持。
使用综合得分对五个种族/民族的现有甲基化数据进行综合分析
SES 以及多种肥胖测量方法将:1) 确定 DNA 甲基化位点。
调节社会经济逆境与肥胖之间的关联,不受当地遗传变异的影响;
2) 整合所有可用的生物社会数据来模拟 SES、肥胖和最终 CVD 之间的路径
该资助机制的资助将使我们能够描述 DNA 甲基化位点的程度。
与 SES 和/或肥胖相关,以及这些变化(或它们与 SES 的相互作用)如何因人而异
我们的研究具有前所未有的创新性。
对祖先多样化样本进行调查、检查和 DNA 甲基化分型的整合。
该项目的预期结果将提高我们对肥胖和心血管疾病的机制理解,并提高我们对肥胖和心血管疾病的认识。
能够识别不同领域针对 CVD 的潜在可行的公共卫生或药物干预措施
人口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lindsay Fernandez-Rhodes其他文献
Lindsay Fernandez-Rhodes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lindsay Fernandez-Rhodes', 18)}}的其他基金
Leveraging Hispanic/Latino diversity to map and characterize cardiovascular disease loci
利用西班牙裔/拉丁裔多样性来绘制和描述心血管疾病基因座
- 批准号:
10587581 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention
运动坚持和认知能力下降:与黑人社区合作制定和测试目标设定和运动强度干预措施
- 批准号:
10767102 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
- 批准号:
10735151 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
帕比司他治疗成人镰状细胞病的 I 期研究:招募和保留的新方法
- 批准号:
10420453 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
ARISE (Achieving Routine Intervention and Screening for Emotional health)
ARISE(实现情绪健康的常规干预和筛查)
- 批准号:
10655877 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Fathers and Children Exercising Together (FACEiT)
父亲和孩子一起锻炼 (FACEiT)
- 批准号:
10789457 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别: